Company Filing History:
Years Active: 2023
Title: Frédéric Knoflach: Innovator in GABA A Modulation
Introduction
Frédéric Knoflach is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as positive allosteric modulators of GABA A receptors. His work has implications for various therapeutic applications.
Latest Patents
Frédéric Knoflach holds a patent for "Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators." This patent describes compounds with a general formula (I), wherein R, R, R, R, R, and X are defined in the documentation. The patent also covers compositions that include these compounds and methods for their use.
Career Highlights
Throughout his career, Frédéric has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Frédéric has collaborated with esteemed colleagues such as Giuseppe Cecere and Luca Claudio Gobbi. These partnerships have fostered innovation and have been instrumental in the progress of his research.
Conclusion
Frédéric Knoflach's work in the field of GABA A modulation showcases his innovative spirit and dedication to advancing pharmacological science. His contributions continue to influence the development of new therapeutic options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.